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Abstract: The study of ion channels and other membrane proteins and their potential use as
biosensors and drug screening targets require their reconstitution in an artiﬁcial membrane. These
applications would greatly beneﬁt from microfabricated devices in which stable artiﬁcial lipid
bilayers can be rapidly and reliably formed. However, the amount of protein delivered to the
bilayer must be carefully controlled. A vesicle fusion technique is investigated where composite ion
channels of the polyene antibiotic nystatin and the sterol ergosterol are employed to render protein-
carrying vesicles fusogenic. After fusion with an ergosterol-free artiﬁcial bilayer, the nystatin–
ergosterol channels do not dissociate immediately and thus cause a transient current signal that
marks the vesicle fusion event. Experimental pitfalls of this method were identiﬁed, the inﬂuence of
the nystatin and ergosterol concentration on the fusion rate and the shape of the fusion event
marker was explored, and the number of different lipid species was reduced. Under these
conditions, the b-amyloid peptide could be delivered in a controlled manner to a standard planar
bilayer. Additionally, electrical recordings were obtained of vesicles fusing with a planar lipid
bilayer in a microfabricated device, demonstrating the suitability of nystatin–ergosterol modulated
vesicle fusion for protein delivery within microsystems.
1 Introduction
Membrane proteins account for an estimated 20–30% of
the human proteome, and many of these ion channels,
receptors and transport proteins play a paramount role in
(patho)physiological processes, as evident from the high
percentage (B60%) of pharmacological drugs that have a
membrane protein target [1–4]. Because they traverse the
hydrophobic interior of cell membranes, integral membrane
proteins inherently have hydrophobic surface areas and this
greatly complicates their characterisation outside a mem-
brane environment, which is reﬂected in the fact that less
than 1% of proteins with a known three dimensional
structure are membrane proteins [5]. For functional studies,
however, a membrane protein can (and should) be present
in a membrane, either in its native biomembrane environ-
ment, as part of a multitude of different protein and lipid
components, or puriﬁed and reconstituted in a model
membrane consisting of a lipid bilayer of selected synthetic
lipids [6].
The electrical conductance of ion channel proteins has
been studied in biomembrane vesicles and in artiﬁcial planar
lipid bilayers by single-channel electrical recordings for
decades [7, 8], yielding valuable information about the ion
selectivity and gating mechanisms of many channels at a
single-molecule level. With the much more recent advances
in single-molecule spectroscopy [9, 10], it is becoming
feasible simultaneously to perform electrical and optical
measurements on single channels, which could provide
insight into the dynamic aspects of ion channel function,
such as subunit assembly, the interaction with regulators of
channel activity, and the conformational transitions asso-
ciated with channel gating [11, 12]. Very recently, such
combined optical and electrical recordings have been
reported for ﬂuorescently labelled analogues of the small
peptide ion channel gramicidin [13, 14] and a potassium
channel [15].
However, the methods demonstrated to date for
simultaneous optical and electrical recordings of ion channel
activity in bilayers are not amenable to integration in an
automated microﬂuidic system. Central to the design of a
suitable technology platform for combined measurements is
a microfabricated device, within which the lipid bilayer is
formed. In recent years, several methods for making such
devices have been reported in the literature [16]. These
devices have been centred around an aperture that is formed
in a hydrophobic material, such as a polymer ﬁlm or
silanised silicon, so that an artiﬁcial planar lipid bilayer can
be formed [17–19]. Furthermore, microfabricated systems
can incorporate many individually addressable membrane
sites, allowing for parallel measurements. We have pre-
viously developed devices based on both micromachined
silicon [20] and polymer embossing technologies [21]. The
former, however, are very limited in their application, owing
to fabrication difﬁculties and to parasitic capacitance E-mail: m.deplanquel@physics.ox.ac.uk
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Microsystems are attractive for many reasons, but
obvious applications are in the ﬁeld of high-throughput
drug screening and biosensor applications [22, 23]. In order
for such systems to operate efﬁciently and reliably, a
controllable method for the delivery of proteins to the
planar bilayer is required. Unlike membrane peptides,
membrane proteins cannot be premixed with the lipid
components in organic solvent. Some peripheral and
integral membrane proteins are able to associate with or
insert into a lipid bilayer directly from aqueous solution, but
these are rare cases and do not include the pharmaco-
logically relevant receptor proteins [3, 4]. Moreover, any
molecule in solution will have to be present in a sufﬁciently
high concentration to enable bilayer contact within a
reasonable time period, but, in this scenario, incorporation
of only a small amount of material, an absolute requirement
for single-molecule studies, is difﬁcult to achieve.
Instead, fusion of small protein-containing vesicles with
the planar bilayer offers signiﬁcant advantages as a delivery
method: in a typical membrane protein puriﬁcation
protocol, detergent removal coincides with vesicle incor-
poration [24], the amount of protein in the vesicles is under
control, and, as vesicle fusion needs to be induced [25, 26],
it can also be prevented once enough fusion has occurred.
In the absence of charged lipids, vesicle fusion is driven
exclusively by osmosis. This only requires an osmotic
gradient over the planar bilayer (established by using
different salt concentrations) and vesicles that are permeable
to solute, as is the case when they contain open channels
[25, 26].
To create permeable vesicles, Woodbury and Miller used
channels that were formed from the polyene macrolide
nystatin [27, 28], an antibiotic secreted by Streptomyces
noursei (Fig. 1). Barrel-like oligomers of polyene macrolides,
such as nystatin and amphotericin B, form weakly anion-
selective channels in the presence of membrane sterols
[32–36], with the largest conductances obtained in the
presence of ergosterol [37–40]. Woodbury and Miller
exploited the dependence of nystatin channel activity on
the presence of a membrane sterol by incorporating the
membrane protein of interest into ergosterol-rich vesicles
containing nystatin, while using an ergosterol-free planar
lipid bilayer. Hence, the nystatin–ergosterol channels
in the vesicles enable vesicle fusion but, following the fusion
event, the nystatin–ergosterol channel activity gradually
disappears as the ergosterol diffuses away into the
ergosterol-free lipid bilayer, while the ion channel activity
of the introduced protein remains (as shown schema-
tically in Fig. 2) [27, 28]. Thus the nystatin–ergosterol
channels not only render the protein-delivering vesicles
fusogenic, but also clearly mark each fusion event as a
transient ion current spike. This easy detection of individual
fusion events is a signiﬁcant advantage for developing
vesicle delivery systems for planar bilayers on microfabri-
cated devices.
In the present study, experimental pitfalls of the nystatin–
ergosterol vesicle fusion method were identiﬁed, and several
parameters of the method were varied using a standard
planar bilayer workstation. The inﬂuence of the nystatin
and ergosterol concentration on the fusion rate and the
conductance of the fusion event marker was explored, and
the lipid composition of the planar bilayer and the vesicles
was simpliﬁed. Optimised conditions were established to
enable us to incorporate the b-amyloid peptide, which has
been implicated in Alzheimer’s disease [41], in a controlled
and reliable manner into a standard planar bilayer, and also
Fig. 1 Molecular components of the nystatin–ergosterol vesicle
fusion method
Nystatin is a mixture of structurally similar polyene macrolide
antibiotics secreted by Streptomyces noursei, of which nystatin A1 is
the main component [29]. An estimated eight nystatin molecules form
a barrel-stave type pore in which the polyhydroxy moieties line the
aqueous channel, and the tetraene groups are in contact with the lipid
acyl chains of the membrane. The nystatin–nystatin interaction is
stabilised by sterol molecules, with ergosterol being more effective than
cholesterol. Because ergosterol is abundant in fungal cell membranes,
nystatin and related polyene macrolides such as amphotericin B are
widely used as fungicidal agents [30]. Note that the effective length of
the acyl chains in bilayers of phospholipids such as 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphatidylcholine (POPC) is reduced because of
chain disordering, whereas the macrolide ring of nystatin is relatively
rigid, enabling a single polyene macrolide molecule to span a
(relatively thin) POPC bilayer [31, 36]
Fig. 2 Schematic diagram of the nystatin–ergosterol vesicle fusion
method
Vesicles containing nystatin, ergosterol and the membrane protein of
interest are added to the solution surrounding a lipid bilayer (1). The
nystatin and ergosterol associate to form multimeric channels that
facilitate fusion of the vesicles with the bilayer (2), with each fusion
event being marked by a rapid increase in the recorded current, owing
to ionic conduction through the nystatin–ergosterol channels. How-
ever, the current due to these channels gradually decreases to the
baseline, as the ergosterol diffuses away into the ergosterol-free bilayer
(3), thereby causing the nystatin–ergosterol channels to dissociate,
while the membrane protein of interest remains active (4)
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2 Materials and methods
2.1 Materials




were purchased from Avanti Polar Lipids (Alabaster, AL).
Anhydrous methanol (99.8%), chloroform (99.9%), decane
(Z99%), triﬂuoroacetic acid (TFA, Z99%) and triﬂuor-
oethanol (TFE, Z99%) were obtained from Aldrich
(St. Louis, MO). Ergosterol (Z75%) was obtained from
Sigma (St. Louis, MO). Nystatin dihydrate, as a mixture
of different nystatin species, was obtained from Sigma,
ICN Biomedicals (Aurora, OH) and Fluka (Buchs,
Switzerland), and nystatin A1 trihydrate was obtained
from Riedel-de Ha. en (Seelze, Germany). b-amyloid
(1–40) peptide was provided by Dr Dirk T.S. Rijkers
(Department of Medicinal Chemistry, Utrecht University,
The Netherlands).
2.2 Nystatin solubilisation
Nystatin is poorly soluble (4mgml
 1 in water and
11.2mgml
 1 in methanol at 28 1C [42]) and chemically
unstable; solutions and aqueous suspensions begin to lose
antifungal activity soon after preparation [43]. In our
experience, reproducible vesicle fusion can only be obtained
when the starting material is a ﬁne powder with a pale
yellow colour. This indicates that the material is relatively
anhydrous, a requirement for solubilisation in methanol.
When nystatin is supplied as a light brown material with a
somewhat sticky consistency, lyophilisation (after initial
suspension in anhydrous methanol and bath sonication) is
necessary to remove adsorbed atmospheric water, but this
treatment is not always effective. In recent experiments, we
used either lyophilised nystatin dihydrate from Fluka or
nystatin A1 trihydrate as supplied. Only fresh stock
solutions in anhydrous methanol were used for sample
preparation, and exposure of the nystatin solution and
samples to light was minimised. Also stock solutions of
ergosterol (recrystallised twice from ethanol) in chloroform
need to be protected from light, although these can be
stored for months at –201C.
2.3 Unilamellar vesicle preparation
Aliquots of stock solutions (B25mM) of POPC, POPE
and POPS in methanol/chloroform (1/1, v/v) and of
ergosterol in chloroform were mixed in the desired molar
ratio, the organic solvents were evaporated under a stream
of nitrogen, and the resulting lipid ﬁlm (containing 7.5mmol
total lipid) was dried overnight under high vacuum to
remove residual solvent traces. This ﬁlm was hydrated with
1ml of high-salt buffer [10mM HEPES, pH 7.4, 720mM
NaCl], and the resulting suspension of multilamellar vesicles
was subjected to between 5 and 10 freeze–thaw cycles to
improve the size homogeneity of the multilamellar vesicles.
Using a mini-extruder (Avanti Polar Lipids), the vesicle
suspension was passed 21 times through a polycarbonate
ﬁlter with a pore size of 400nm (Whatman; Clifton, NJ),
resulting in a suspension of unilamellar vesicles of the same
diameter. Subsequently, typically 10ml of a freshly prepared,
bath sonicated (B10min, 201C, 350W power, 2.75l bath
volume), clear solution of nystatin in anhydrous methanol
(1mgml
 1) was added to 200ml of the vesicle suspension,
resulting in a nystatin concentration of 50mgml
 1 (54mM).
The nystatin-containing vesicle samples were incubated at
room temperature, with occasional vortexing, to allow time
for the nystatin molecules to associate with the vesicles [39].
For samples with the b-amyloid (Ab)p e p t i d e ,0 . 1 5mmol of
Ab was predissolved in TFA [44], the excess of TFA was
r e m o v e dw i t han i t r o g e nﬂ o w ,a n dt h eA b–TFA ﬁlm was
redissolved in TFE. This solution was added to a lipid
mixture in organic solvent and dried, resulting in a mixed
ﬁlm with a peptide to lipid molar ratio of 1:200, which was
then treated in the same way as a peptide-free lipid ﬁlm.
2.4 Electrical bilayer recordings in
conventional systems
Planar lipid bilayers were formed across a 150mm aperture
in the wall of a Delrin cup with a working volume of 1ml
(Warner Instruments; Hamden, CT). A small amount of
a POPE–POPC (7:3molar ratio) solution in decane
(20mgml
 1) was applied to the area around the aperture
and was allowed to air dry. The cup was placed in a bilayer
chamber (Warner Instruments), the cis and trans chambers
were both ﬁlled with 1ml of low-salt buffer [10mM
HEPES, pH 7.4, 150mM NaCl], and a planar lipid bilayer
was painted by depositing a small drop of the lipid-
containing decane solution on the aperture. Formation and
thinning of the bilayer were monitored by capacitance
measurements; ﬁnal capacitance values ranged from 70 to
100pF, corresponding to bilayers of speciﬁc capacitance of
approximately 0.5mFcm
 2. Subsequently, a 100ml aliquot
was removed from the cis chamber and replaced with 100ml
of a 3M NaCl solution in distilled water, and the chamber
contents were carefully mixed. This procedure was repeated
once with 100ml and once with 50ml of 3M NaCl, giving a
ﬁnal cis chamber NaCl concentration of 720mM. The cis–
trans salt gradient facilitates vesicle fusion [45, 46]. Between
2a n d1 0ml of vortexed vesicle suspension was added to the
cis chamber, near the aperture. A membrane holding
potential of 65–100mV was applied, with Ag/AgCl
electrodes positioned directly in the cis and trans (virtual
ground) chambers, and the current signal, ﬁltered at 1kHz,
was measured using a bilayer membrane admittance meter
(model ID 562, Industrial Development Bangor; Gwynedd,
UK). The signal was digitised with a BNC-2110 adapter
and connected to a personal computer with a PCI-6014
data acquisition board (National Instruments; Austin, TX).
Current data points were recorded at a rate of either 250 or
2500Hz with LabView software (National Instruments),
and single-channel conductance events were analysed using
pClamp 9 software from Axon Instruments (Foster City,
CA).
2.5 Electrical bilayer recordings on-chip
Although traditional silicon fabrication methods are well
developed and offer the potential for high-resolution
devices, these methods are often costly and time-consuming.
Therefore rapid manufacturing techniques, such as hot
embossing, injection moulding and soft lithography, are
increasingly being employed for the production of micro-
ﬂuidic systems [47]. These techniques focus on the
manufacturing of low-cost polymeric devices with a rapid
turnaround time. The use of hot-embossing was explored
for fabricating a microﬂuidic channel to obtain the cis
reservoir [20], and an aperture (100mm diameter, o120mm
thickness) was created in the centre of this channel by laser
micromachining. A poly(methylmethacrylate) (PMMA)
well was placed over the aperture to act as the cis reservoir,
and the base of the channel was sealed using a glass
coverslip (as illustrated in Fig. 3a).
IEE Proc.-Nanobiotechnol., Vol. 153, No. 2, April 2006 23
Downloaded 24 Jul 2006 to 135.196.14.254. Redistribution subject to IEE licence or copyright, see http://ieedl.org/copyright.jspBilayers were made by painting the same lipid mixture
(Section 2.4) over the poly(tetraﬂuoroethylene) (PTFE)
aperture using a brush. Thinning of the decane-lipid ﬁlm
was observed within a few minutes, resulting in a stable lipid
bilayer that could be used over several hours. The thinning
process was observed by transmission microscopy, as a
lighter region was seen gradually to expand outwards as the
bilayer formed, leaving a distinct annulus visible around the
aperture (Fig. 3b). Simultaneously, the capacitance and
conductance of the bilayer were monitored, using the same
equipment as for the experiments reported above (Section
2.4). Final capacitance values ranged from 30 to 45pF,
corresponding to bilayers with a speciﬁc capacitance of
approximately 0.6mFcm
 2. Vesicles were made in the same
way as described above (Section 2.3), with 10mol%
ergosterol and 50mgml
 1 nystatin (but with 7.5mMi n s t e a d
of 7.5mM total lipid), and the same salt gradient was
created between the two chambers, with the quantities to be
injected adjusted according to the cis reservoir volume,
which is only B50ml.
3 Results and discussion
3.1 Nystatin concentration modulates
vesicle fusion
Figure 4 shows different electrical recordings of a planar
bilayer consisting of a mixture of the phospholipids POPE
and POPC. In the absence of incorporated ion channels, the
bilayer had a high resistance, and, consequently, the applied
voltage did not result in a signiﬁcant current. Current spikes
were observed when unilamellar phospholipid-ergosterol
vesicles, incubated with nystatin, were added to the aqueous
solution on one side of the planar bilayer. Each current
Fig. 3 Schematic cross-section of microﬂuidic device
a Schematic cross-section of the microﬂuidic device used in this work,
which comprised a hot-embossed poly(tetraﬂuoroethylene) microﬂui-
dic channel with a laser micromachined aperture (thickness o120mm)
where the bilayer was formed. The microﬂuidic channel was bonded to
a glass coverslip (22 40mm) and a poly(methylmethacrylate)
reservoir with a height of B2mm and a volume of B50ml
b Typical transmission microscope image of a bilayer in the aperture
Fig. 4 Inﬂuence of nystatin concentration on vesicle fusion
Current traces of a planar bilayer of POPE/POPC (7:3molar ratio) voltage clamped at +100mV. Recordings were started immediately after
injection of 20ml of vesicle suspension and mixing by raising and lowering of the buffer in the cis compartment. Vesicles are composed of POPE/










The asterisk denotes an interruption of the recording to raise and lower the buffer, a procedure which usually results in a new cycle of vesicle fusion
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channels into the planar bilayer by a single vesicle fusion
event. The abrupt increase in bilayer conductance reﬂects
the short time scale of vesicle fusion, whereas the following
gradual current decrease is caused by the diffusion-driven
dissociation of the nystatin–ergosterol channels in the
ergosterol-free planar bilayer. The amplitude of the current
spikes and the time required for their decay depends on the
concentration of nystatin and ergosterol, and typical
working conditions are a nystatin concentration of
50–60mgml
 1, a vesicle ergosterol content of 20–30mol%
and a total lipid (phospholipid and sterol) concentration
of 7.0–7.5mM [27, 28, 48, 49].
In this study, we investigated the effect of varying the
nystatin and ergosterol concentration on several parameters
that are relevant for vesicle fusion and protein delivery to
planar bilayers. The recording shown in Fig. 4a was
obtained with vesicles of POPE/POPC/POPS containing
20mol% ergosterol, which were incubated with 60mgml
 1
of nystatin. After injection of the vesicle suspension into the
cis compartment and mixing by raising and lowering of the
solution in the compartment, a large number of vesicles
(about 15) fuse within the ﬁrst minute. Subsequently, the
fusion rate slows down, and, 2min after injection, fusion
has stopped, except for an isolated event near the end of the
recording. The amplitude of the current spikes varies
considerably, with values ranging from 3 to 35pA, most
likely reﬂecting non ideal mixing of the nystatin stock
solution and the vesicle suspension. Complete decay of the
current spikes takes B10s for the events with lower
amplitude and B25s for the most intense spikes, and,
consequently, most fusion markers overlap. When the same
experiment was carried out with 50mgml
 1 nystatin
(Fig. 4b), fusion only occurred within the ﬁrst 1.5min after
vesicle injection, the average spike amplitude was about
30% lower, the current decay time was shorter (5–10s), and
consequently the fusion markers show considerably less
overlap. A very different picture emerges when the nystatin
concentration is lowered further to 40mgml
 1, as seen in
Fig. 4c, where only a small number of fusion events were
recorded, and most of these were later than 2min after
injection. The current spikes do not exceed 15pA, and
complete current decay takes about 60s. At a nystatin
concentration of 30mgml
 1, no fusion events were observed
until the solution in the compartment had been raised and
lowered again. This procedure usually generates a fresh
burst of vesicle fusion, but for this sample only an isolated
low-amplitude fusion event occurred (Fig. 4d).
It appears that controlled fusion of vesicles is only
attainable within a surprisingly narrow nystatin concentra-
tion range: 60mgml
 1 results in too much fusion, and, with
40mgml
 1, most fusion events are characterised by an
unfavourable low-amplitude current spike and a slow
current decay. This implies that vesicle fusion will not be
observed when the nystatin is not properly solubilised (see
Section 2.2). The abrupt change in fusion characteristics
below 50mgml
 1 nystatin can be explained by a recent
ﬂuorescence lifetime study on the interaction of nystatin
with ergosterol-containing POPC vesicles [39]. Coutinho
et al. could distinguish nystatin molecules that are bound to
the vesicle surface from molecules that have actually
penetrated into the bilayer core. The latter, channel-forming
population abruptly arises when B50mgml
 1 nystatin is
present (extrapolated value for a 7.5mM total lipid vesicle
suspension), whereas, at lower concentrations, all the
nystatin molecules remain surface-associated. At this
threshold amount of nystatin, an estimated 1% of the
vesicle surface is covered with nystatin molecules [39].
Surface-associated nystatin molecules will be partly inserted
into the lipid headgroup region, and, although this
arrangement is sufﬁciently perturbing for lipid packing to
result in channel-like activity [50], vesicle fusion will not give
rise to the current spikes that are characteristic of
dissociating nystatin–ergosterol channels (Figs. 4a and b).
3.2 Composition of unilamellar vesicles
For a concentration of 50mgml
 1 nystatin, the effect of
different ergosterol molar ratios in the vesicles was
investigated. Figure 5b shows the ﬁrst 3min after vesicle
injection of a current trace recorded for vesicles with
20mol% ergosterol. Although this is the same composition
as used to obtain the trace in Fig. 4b, the number and shape
of the fusion-induced current spikes also display features of
the trace in Fig. 4a, indicating a slight variation in the
(effective) nystatin concentration for this separate set of
samples. When the ergosterol content is increased to 25%
(Fig. 5a), the current spikes have a signiﬁcantly longer decay
time (460s), reﬂecting the longer time required for the
larger amount of incorporated ergosterol to diffuse away
into the planar bilayer. Lowering the ergosterol content
instead to 15% reduces the current decay time to B10s for
the spikes with 15–20pA amplitude and to B20s for the
low-intensity events, and most of the current spikes are
almost separated from each other, although there is
virtually no time interval between fusion events (Fig. 5c).
However, when only 10% of the vesicle composition is
ergosterol, the number of fusion events decreases, as does
the current decay time, which is now o10s for a current
spike of 35pA and B5s for an event with an intensity of
10pA (Fig. 5d). With 5% ergosterol in the vesicles, fusion
could not be observed.
This combination of a low vesicle fusion rate with easily
observable and rapidly decaying current spikes led us to use
10% ergosterol and 50mgml
 1 nystatin for all subsequent
measurements. The number of fusing vesicles can be further
reduced by injection of less than the 20 mlo fv e s i c l e
suspension used in these experiments (see below), or by
using a more dilute vesicle suspension. We also evaluated
the effect of the POPS component on fusion, initially
introduced to mimic the composition of synaptic vesicles
[27]. The absence of this negatively charged lipid did not
inﬂuence vesicle fusion (data not shown) and reduces the
number of ‘foreign’ molecules that are introduced into
the planar bilayer of POPE and POPC. The presence of the
curvature-preferring [51] lipid POPE in the vesicles is
essential for fusion, but an occasional fusion event is
observed when the planar bilayer is composed exclusively of
POPC, in agreement with previous work [26]. Although we
used unilamellar vesicles with a diameter of 400nm, vesicle
fusion was also successful with vesicles with a diameter of
100nm (data not shown). This is the lower limit of the
vesicle size range of 100–1000nm previously recommended
for the nystatin-fusion method [28].
3.3 Example of ion-channel delivery by
vesicle fusion
To demonstrate incorporation of a membrane peptide into
a planar bilayer by nystatin–ergosterol modulated vesicle
fusion, vesicles were prepared containing Ab(1–40), the
shorter of the two beta-amyloid peptides that are abundant
in the ﬁbrillar plaques associated with Alzheimer’s disease
[41]. In its unstructured monomeric form, the Ab peptide
can bind to charged membrane surfaces but not to the net
uncharged surface of a POPE/POPC bilayer [52]. However,
Ab has a high tendency in aqueous solution to form b-
structured oligomers and ill-deﬁned aggregates, which cause
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ments [53, 54]. Premixing peptide and lipids in organic
solvent (see Section 2) should result in stable association of
Ab with the vesicles, and, as non-vesicular Ab cannot bind
to the planar bilayer in its monomeric form and would
induce large currents (4100pA under our experimental
conditions [53]) in its oligomeric form, incorporation of Ab
by vesicle fusion ought to be easily recognised.
As shown in Fig. 6, injection of a suspension of vesicles
containing 0.5mol% of Ab results in controlled incorpora-
tion of the peptide into the planar bilayer. The ﬁrst clear
vesicle fusion event causes irregular, low-intensity current
‘activity’, and the second clear fusion event results in
continuous channel-like activity of Ab,w h i c hc a nb e
studied after the nystatin–ergosterol channels have disso-
ciated (see inset). It should be noted that the current decay
of the nystatin–ergosterol channels takes longer than for
peptide-free vesicles with the same lipid composition,
suggesting that the presence of the peptides inﬂuences the
diffusion rate of ergosterol. Because the onset of Ab activity
coincides with vesicle fusion, and excessive conductances are
not observed, it can be concluded that the Ab peptides are
delivered to the planar bilayer by vesicle fusion and have
not incorporated from the aqueous phase. The expanded
trace (Fig. 6, inset) reveals that the Ab activity is similar to
the channel-like ‘spiky fast’ behaviour of Ab,a ss e e nw h e n
small amounts of monomeric peptide are added to a
charged bilayer from aqueous solution [55], illustrating the
potential of vesicle fusion to introduce controlled amounts
of protein or peptide in a planar bilayer.
3.4 Vesicle fusion on chip
The nystatin–ergosterol vesicle fusion method was also
investigated for a planar bilayer on a chip. Only stable
bilayers with an electrical leakage current of below 0.1pA
(at an applied potential of +65mV) were used. The
stability of these bilayers was comparable with that of
the bilayers in the conventional bilayer apparatus; planar
bilayers that exhibited a constant capacitance and a
minimum leakage for several hours could readily be
obtained with both systems, although there are variations
between individual experiments. Vesicle fusion in the
microdevice was initiated by introducing a small volume
of vesicle suspension (7.5mM total lipid; 10
9vesiclesml
 1)
into the upper chamber of the horizontal bilayer using a
pipette. Vesicles slowly diffused through the suspending
Fig. 5 Inﬂuence of ergosterol concentration on vesicle fusion
Current traces of a planar bilayer of POPE/POPC (7:3molar ratio) voltage clamped at +100mV. Recordings were started immediately after
injection of 20ml of vesicle suspension and mixing by raising and lowering of the buffer in the cis compartment. Vesicles are incubated with
50mgml
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fusion was observed within the ﬁrst few minutes, the buffer
solution was gently agitated with a pipette, which normally
resulted in vesicles fusing with the bilayer. As with the
conventional system, vesicle fusion does not alter
the stability or the capacitance of the bilayer, as long as
the number of fusing vesicles is not excessive. A typical
vesicle fusion trace obtained with the chip is shown in
Fig. 7, where three separate fusion events are detected, each
showing the ‘classical’ decay of current with time, as the
nystatin–ergosterol channels dissociate in the large planar
bilayer. Also in this respect, the behaviour of the
microdevice was similar to the conventional bilayer
apparatus (Fig. 5d).
3.5 Molecular mechanism of nystatin–
ergosterol current decay
Because the composite channels of the polyene antibiotics
and ergosterol have not been characterised at the single-
channel level, the conductance of a single nystatin–ergo-
sterol channel is not known, and therefore it is a matter of
debate how many nystatin–ergosterol channels contribute
to the current spike associated with vesicle fusion. Based on
the very low conductance (B2pS) reported for single
channels of nystatin–cholesterol [56, 57], and on the large
number of nystatin molecules available for each vesicle
(B1000 for vesicles of 100nm), it has been suggested that
hundreds of low-conductance nystatin–ergosterol channels
contribute to the current spike [27]. However, the recent
ﬂuorescence lifetime study discussed above [39] demon-
strates that a large number of nystatin molecules at the
vesicle surface is required before nystatin penetrates the
vesicular membrane, suggesting that only a fraction of the
nystatin molecules actually participate in channel forma-
tion. Moreover, at a nystatin–lipid ratio close to our
experimental conditions, analysis of the kinetics of K
+
efﬂux from the vesicles indicates that, on average, there are
only B1.5 pores per vesicle present [39].
Signiﬁcantly, after a substantial amount of vesicle fusion
under the conditions described for Fig. 4b, we observed
single channel behaviour in the absence of membrane
proteins or peptides. The current trace in Fig. 8a shows
continuous single-channel activity and two vesicle fusion
events. This can be interpreted as a single nystatin–
ergosterol channel that does not dissociate because it is
present in a stable, ergosterol-rich domain [58] of the planar
bilayer, created by substantial amounts of vesicle fusion.
The two vesicles that fuse at 11 and 16s in this trace are
marked by a normal gradual current decay, corresponding
to dissociation of the incorporated nystatin–ergosterol
channels in an ergosterol-poor region of the planar bilayer.
The observation that the initial current of the vesicle fusion
spikes (B12pA) is very similar to the amplitude of the
single nystatin–ergosterol channel, strongly suggests that
the vesicles only deliver one nystatin–ergosterol channel to
the planar bilayer.
A histogram of the distribution of channel openings and
closings (Fig. 8b) shows that the single channel is most often
in a low-conductance state (B10–50pS under the condi-
tions described in the Caption) and frequently in a high-
conductance state (B170pS), whereas it is very rarely
closed. Complete closure of the channel is visible at 0.2, 2.4
and 6.8s in the expanded trace (Fig. 8c), which also
shows typical lifetimes of the two conductance states at
the applied potential of +100mV. At lower, and especially
at negative potential, the frequency of occurrence and the
lifetime of the high-conductance state were greatly reduced,
and the low-conductance state was increasingly favoured.
From  50 to +50mV, the current–voltage relationship [59]
of the single nystatin–ergosterol channel (Fig. 8d)i s
characterised by a slope conductance of 4972pS and
26572pS for the low-conductance and high-conductance
states, respectively. The reversal potential for both states is
+16mV, indicating that the channel is weakly anion
selective, as previously observed for nystatin–cholesterol
channels [32, 33].
Fig. 6 Controlled delivery of Ab(1–40) to a lipid bilayer by vesicle
fusion
Current trace of a planar bilayer of POPE/POPC (7:3molar ratio)
voltage clamped at +100mV. Recordings were started immediately
after injection of 10ml of vesicle suspension and mixing by raising
and lowering of the buffer in the cis compartment. Vesicles are
composed of POPE/POPC/ergosterol¼6:3:1 (molar ratio) and
are incubated with 50mgml
 1 of nystatin. The molar ratio of
Ab(1–40) to total lipid in the vesicles is 1:200. The inset presents an
expanded view of the end of the recording, when the nystatin–
ergosterol channels have dissociated and only the conductance
resulting from the introduced Ab(1–40) peptide remains
Fig. 7 E l e c t r i c a lr e c o r d i n go nc h i p
Current trace of a planar bilayer of POPE/POPC (7:3molar ratio)
voltage clamped at +65mV. The planar bilayer is formed on a chip
and the trace is recorded after injection of 4ml of diluted vesicle
suspension (7.5mM total lipid) to the upper chamber. Vesicles are
composed of POPE/POPC/ergosterol¼6:3:1 (molar ratio) and
are incubated with 50mgml
 1 of nystatin. Three fusion events
are visible
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vesicle fusion (vesicle composition as in Fig. 7) into planar
bilayers of POPC which contain 3.571mol% ergosterol.
Lower ergosterol concentrations resulted in a standard
(although elongated) decaying current spike, whereas higher
concentrations gave rise to a constant current that
corresponds to the channel high-conductance state (data
not shown). Apparently, in a bilayer with only B3.5%
ergosterol, nystatin–ergosterol channels introduced by
vesicle fusion cannot dissociate but are sufﬁciently destabi-
lised to enable (partial) channel closing and reopening.
Based on the preliminary characterisation of a single
nystatin–ergosterol channel presented here, we propose that
vesicle fusion typically leads to the incorporation of only
one or two nystatin–ergosterol channels into the planar
bilayer, and that the gradual decay of the current spike
represents the gradual inactivation of this small number of
channels.
In this scenario, the shape of the current spike will be
inﬂuenced by the location of the channels in the patch of
phospholipids and ergosterol inserted into the planar bilayer
by vesicle fusion. Compared with channels near the centre
of this patch, channels near the edge will dissociate more
rapidly through diffusion of their ergosterol components,
because they are in closer proximity to the ergosterol-free
part of the planar bilayer. In general, the mechanism of
nystatin–ergosterol channel formation and dissociation
illustrates the necessity of combined optical and electrical
recordings to understand the assembly, function and
regulation of (multimeric) ion channel proteins.
4 Conclusions
With correct handling of the nystatin component, the
nystatin–ergosterol vesicle fusion technique is a promising
method for the controlled incorporation of membrane
peptides and proteins into artiﬁcial lipid bilayers. We
have shown delivery of a small amount of the Ab(1–40)
peptide to a conventional planar bilayer and have
demonstrated vesicle fusion with a bilayer in a micro-
fabricated device. Particularly in combination with
microﬂuidics technology, the time between vesicle
fusion events is sufﬁciently long to neutralise the salt
gradient and thus to prevent additional protein incorpora-
tion by vesicle fusion. The potential of the nystatin–
ergosterol vesicle fusion method to deliver puriﬁed ion
Fig. 8 Single nystatin–ergosterol channel activity
a Snapshot of single nystatin–ergosterol channel activity after a substantial amount of vesicle fusion (vesicle composition: molar ratio POPE/POPC/
POPS/ergosterol¼4:2:2:2, 50mgml
 1 nystatin) into a planar bilayer of POPE/POPC (7:3). The current trace, recorded at +100mV in the
presence of an osmotic gradient (cis/trans¼720/150mM NaCl), also shows two vesicle fusion events (denoted by asterisks)
b Histogram showing the distribution of conductances after neutralisation of the osmotic gradient (cis/trans¼720/720mM NaCl, +100mV holding
potential)
c Expanded view of a current trace recorded at +100mV holding potential in the absence of an osmotic gradient (cis/trans¼720/720mM NaCl);
the high-conductance, low-conductance and closed state of the single channel can clearly be distinguished
d Current–voltage relationship of the low-conductance and the high-conductance states in symmetrical conditions of NaCl (cis/trans¼720/720mM)
28 IEE Proc.-Nanobiotechnol., Vol. 153, No. 2, April 2006
Downloaded 24 Jul 2006 to 135.196.14.254. Redistribution subject to IEE licence or copyright, see http://ieedl.org/copyright.jspchannel proteins to conventional planar bilayers has
already been demonstrated [60], and our future efforts
will focus on the incorporation of a ﬂuorescently labelled
multimeric membrane protein into a bilayer on a chip.
Such devices will have widespread potential applications,
for instance in the ﬁelds of single-molecule biophysics,
drug-screening technologies and in the development of
high-sensitivity biosensors.
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